Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron replacement after upper gastrointestinal bleeding
2009-014016-35Phase 4Completed
- Sponsor
- Aarhus University Hospital, Department of Hepatology and Gastroenterology
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ferric carboxymaltose, ferrous sulfate and dextriferron in iron deficiency anemia (IDA) (3 arms), sponsored by Aarhus University Hospital, Department of Hepatology and Gastroenterology. Primary endpoint: Change in hemoglobin level. Started Aug 2009; status: completed.
02
Drugs
ferric carboxymaltoseferrous sulfatedextriferron
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2009-014016-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014016-35.